Q4 production of 224.9 kboepd (-1.3% vs. ARCe)FY'23 production of 213 kboepd (in line with guidance 210-220 kboepd)Update points towards Q4 revenue of USD 1,680m (-2.2% vs. ARCe & -4.8% vs. current BB cons)Takes Balder impairment of USD 530m (pre-tax) due to increased costs and lower forward prices
